Do diabetes shots affect joint health?

Original Title

Five-year Incidence of Progression to Osteoarthritis and Total Joint Arthroplasty in Patients Prescribed Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists.

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

This study looked at whether people with diabetes who take GLP-1 drugs are more likely to get joint problems in their hips or knees over five years.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

GLP-1-RAs were linked to *worse* joint outcomes in diabetics, despite prior research suggesting they might protect joints.

Earlier studies proposed that GLP-1 drugs could reduce inflammation and even reverse joint damage. This large observational study found the opposite in diabetic patients — a 50–78% higher risk of OA progression.

Practical Takeaways

If you have diabetes and are starting a GLP-1 drug, discuss joint health monitoring with your doctor, especially if you have existing joint pain.

low confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.